P-glycoprotein inhibitors (class)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for P-glycoprotein inhibitors (class), covering 2016-04-22 to 2016-04-22. Get the full timeline:
Most recent: Clinical Trial Update: P-glycoprotein Inhibition as Adjunct Treatment for Medically Refractory Epilepsy. [Phase 2, Phase 3]